Company Overview and News

 
Kalyani Steels Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Financials, FMCG, oil stocks drag Nifty below 10,400; Sensex loses 150 pts, midcaps outperform

2018-03-15 moneycontrol
The market failed to hold on to gains on Thursday as benchmark indices saw selling pressure in late trade and Nifty, Sensex fell half a percent each despite recovery in Asian peers and positive trade in Europe.
Upvote Downvote

 
Closing Bell: Sensex falls 150 pts, but midcaps outshine; IOC, Yes Bank top losers

2018-03-15 moneycontrol
3:30 pm Market Closing: Benchmark indices closed lower despite upside in European peers, with the Sensex falling 150.20 points to 33,685.54.
Upvote Downvote

 
Sundaram Trading buys 2.39 lakh shares of Kalyani Steels

2018-03-13 moneycontrol
On March 12, 2018 Gloxinia Investment And Finance sold 2,35,000 shares of Kalyani Steels at Rs 287.57 on the NSE.
Upvote Downvote

 
High-flying graphite electrode companies in India face price curbs

2018-02-20 business-standard
Indian manufacturers of graphite electrodes used in electric arc furnaces are booming on the back of China's pollution crackdown, but soaring prices have set the companies on a collision course with government and steelmakers. In an unusual intervention, India's steel ministry is pushing for electrode makers to cut prices for smaller steelmakers after a 500 per cent surge in domestic prices, sources told Reuters.
Upvote Downvote

 
India's high-flying graphite electrode firms face curbs

2018-02-19 in.reuters
NEW DELHI (Reuters) - Indian manufacturers of graphite electrodes used in electric arc furnaces are booming on the back of China’s pollution crackdown, but soaring prices have set the companies on a collision course with government and steelmakers.
Upvote Downvote

 
Nearly 200 stocks hit 52-week lows

2018-02-06 thehindubusinessline
Around 188 stocks, including Aditya Birla Capital, Andhra Bank, Bajaj Hindusthan Sugar, BGR Energy Systems, Central Bank of India, Cummins India, and Godfrey Phillips India, hit fresh 52-week lows on the BSE.
Upvote Downvote

 
Closing bell: Sensex falls 310 pts, Nifty ends below 10,700; HDFC twins drag

2018-02-05 moneycontrol
3:30 pm Market Closing: Benchmark indices closed sharply lower on Monday as the Sensex was down 309.59 points or 0.88 percent at 34,757.16, and the Nifty fell 94.10 points or 0.87 percent to 10,666.50, dragged by private banking & financials.
Upvote Downvote

 
Kalyani Steels hits 52-week high on poor Q3 numbers; PAT down 10%

2018-02-05 moneycontrol
Shares of Kalyani Steels touched 52-week low of Rs 313.90, down 5.6 percent intraday Monday on poor December quarter (Q3FY18) numbers.
Upvote Downvote

 
Kalyani Steels Limited - Financial Result Updates

2018-02-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Market Live: Sensex falls 400 pts, Nifty back above 10,600; VIX rises 8%

2018-02-05 moneycontrol
10:20 am Results today: Tata Motors, Colgate Palmolive, Ujjivan Financial Services, Bosch, Ador Welding, Alkyl Amines, Astrazeneca Pharma, Century Plyboards, Cochin Shipyard, BASF, Cosmo Films, ENIL, Eveready Industries, Greaves Cotton, HUDCO, IFCI, Igarashi Motors, JSW Holding, Kalyani Steels, MM Forgings, Mcleod Russel, Mold-Tek Packaging, Omkar Specialty chemicals, Panama Petrochem, Sheela Foam, Timken, Themis Medicare, Tribhovandas Bhimji Zaveri, Usha Martin, Weizmann Forex and Westlife Development will announce earnings today.
Upvote Downvote

 
Hike in iron ore prices will affect steel sector, says Kalyani Steels

2018-01-03 moneycontrol
NMDC has taken a steep increase in prices of fines and lumps, taking prices to nearly three year highs.
Upvote Downvote

 
Kalyani Steels Limited - Updates

2017-12-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Kalyani Steels, Anjani Portland, NHPC down 4-7% on dismal Q2 nos

2017-11-09 moneycontrol
Shares of Kalyani Steels, Anjani Portland and NHPC slipped 4-7 percent intraday Thursday on poor September quarter (Q2FY18) numbers.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...